Please provide your email address to receive an email when new articles are posted on . “These patients are excluded from clinical trials on biologics and available studies on the effectiveness of ...
People with ulcerative proctitis, a milder and more limited form of ulcerative colitis, are not at higher risk of developing rectal cancer than the general population. This is shown in a new Swedish ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio New data showed similar clinical and ...
Previous Phase 1b clinical data suggest niclosamide delivers favorable efficacy compared to topical corticosteroid in the treatment of ulcerative proctitis and ulcerative proctosigmoiditis BOCA RATON, ...
People with ulcerative proctitis, a milder and more limited form of ulcerative colitis, are not at higher risk of developing rectal cancer than the general population. This is shown in a new Swedish ...
BEVERLY, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to inform shareholders that the United ...
After two weeks of the abdominal pains and bloody bowel movements, Brett knew he had to be seen. In March of 2016, Brett had his first colonoscopy and was initially diagnosed with ulcerative proctitis ...
SADDLEBROOK, N.J.--(BUSINESS WIRE)--Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a generic version of Canasa®, (mesalamine) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results